Stay updated with breaking news from Treating Field. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tony S.K. Mok, MD, BMSc, FRCPC, FASCO, highlights novel partners and potential new approaches for immunotherapy-based regimens for the treatment of patients with non–small cell lung cancer.
Jarushka Naidoo, MBBCh, discussed the clinical significance of datasets from several phase 3 trials presented at the 2023 ASCO Annual Meeting, including ADAURA, KEYNOTE-617, CheckMate 816, and CheckMate 9LA trials.
However, device was not tested alongside current standard of care, expert points out
/PRNewswire/ -- The "Glioblastoma Multiforme (GBM) Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report...
/PRNewswire/ -- The global glioblastoma multiforme treatment market was valued at around US$ 2.6 Bn in 2021. According to Fact.MR, overall sales of...